| |
| |
|
| Insider
Information: |
Daniels Brian |
| Relationship: |
SVP Global Dev & Med ... |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
94,374 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,219,462 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
94,374 |
|
|
| Total
Value |
$4,219,462 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
SVP Global Dev & Med ... |
2014-07-01 |
94,374 |
2008-03-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
68 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMY |
Bristol-Myers Squibb Co |
SVP Global DevelopmentOfficer |
• – – |
2008-03-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
37,141 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Global Development |
• – – |
2008-03-06 |
4/A |
OE |
$0.00 |
$0 |
D/D |
2,366 |
39,507 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Global Development |
• – – |
2009-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
8,650 |
44,654 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Global Dev & Med Affairs |
• – – |
2010-03-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,919) |
41,659 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Global Dev & Med Affairs |
• – – |
2010-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,774 |
45,578 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Global Dev & Med Affairs |
• – – |
2010-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,366 |
44,025 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Global Dev & Med Affairs |
• – – |
2011-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
32,822 |
67,626 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Global Dev & Med Affairs |
• – – |
2011-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(11,934) |
55,692 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Global Dev & Med Affairs |
• – – |
2011-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,812 |
59,504 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Global Dev & Med Affairs |
• – – |
2011-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
140 |
59,644 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Global Dev & Med Affairs |
• – – |
2011-03-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,437) |
58,207 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Global Dev & Med Affairs |
• – – |
2011-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,870 |
60,077 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Global Dev & Med Affairs |
• – – |
2011-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,367 |
61,764 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Global Dev & Med Affairs |
• – – |
2012-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,003 |
43,272 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Global Dev & Med Affairs |
• – – |
2012-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,702 |
42,269 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Global Dev & Med Affairs |
• – – |
2012-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,222 |
46,596 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Global Dev & Med Affairs |
• – – |
2012-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,813 |
45,374 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Global Dev & Med Affairs |
• – – |
2012-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,691 |
47,456 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Global Dev & Med Affairs |
• – – |
2012-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,870 |
48,347 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Global Dev & Med Affairs |
• – – |
2012-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
28,073 |
75,740 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Global Dev & Med Affairs |
• • – |
2013-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,691 |
52,701 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Global Dev & Med Affairs |
• • – |
2013-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,870 |
53,569 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Global Dev & Med Affairs |
• • – |
2013-03-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
42,070 |
94,942 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Global Dev & Med Affairs |
• • – |
2013-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,929 |
98,871 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Global Dev & Med Affairs |
• – – |
2014-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
7,516 |
66,626 |
0 |
- |
|
68 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
